Morgan Stanley (MS) Stock Forecast & Price Target

$123.44 +2.94 (+2.44%)

(As of 12/20/2024 05:45 PM ET)

Morgan Stanley - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Hold

Based on 17 Analyst Ratings

Sell
0

Hold
11

Buy
6

Based on 17 Wall Street analysts who have issued ratings for Morgan Stanley in the last 12 months, the stock has a consensus rating of "Hold." Out of the 17 analysts, 11 have given a hold rating, and 6 have given a buy rating for MS.

Consensus Price Target

$121.80
-1.33% Downside

According to the 17 analysts' twelve-month price targets for Morgan Stanley, the average price target is $121.80. The highest price target for MS is $142.00, while the lowest price target for MS is $104.00. The average price target represents a forecasted downside of -1.33% from the current price of $123.44.

Get the Latest News and Ratings for MS and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Morgan Stanley and its competitors.

MS Analyst Ratings Over Time

Type	Current Forecast 12/22/23 to 12/21/24	1 Month Ago 11/22/23 to 11/21/24	3 Months Ago 9/23/23 to 9/22/24	1 Year Ago 12/22/22 to 12/22/23
Strong Buy	0 Strong Buy rating(s)	1 Strong Buy rating(s)	0 Strong Buy rating(s)	1 Strong Buy rating(s)
Buy	6 Buy rating(s)	7 Buy rating(s)	6 Buy rating(s)	8 Buy rating(s)
Hold	11 Hold rating(s)	10 Hold rating(s)	13 Hold rating(s)	9 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	1 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$121.80	$112.94	$101.73	$93.51
Forecasted Upside	-1.33% Downside	-16.44% Downside	-0.72% Downside	1.19% Upside
Consensus Rating	Hold	Moderate Buy	Hold	Moderate Buy

URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad)

Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.

>> Register for the Workshop Now

MS Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

MS Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Morgan Stanley Stock vs. The Competition

Type	Morgan Stanley	Finance Companies	S&P 500
Consensus Rating Score	2.35	2.50	2.51
Consensus Rating	Hold	Hold	Moderate Buy
Predicted Upside	-1.33% Downside	18.66% Upside	14.54% Upside
News Sentiment Rating	Neutral News See Recent MS News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
12/6/2024	JPMorgan Chase & Co. 3 of 5 stars		Boost Target	Neutral ➝ Neutral	$100.00 ➝ $104.00	-19.62%
12/3/2024	Keefe, Bruyette & Woods 4 of 5 stars		Boost Target	Market Perform ➝ Market Perform	$121.00 ➝ $138.00	+5.32%
11/26/2024	Hsbc Global Res 0 of 5 stars	S. Martinez Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Strong-Buy ➝ Hold
11/26/2024	HSBC Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Buy ➝ Hold	$128.00 ➝ $131.00	-2.00%
11/25/2024	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Neutral ➝ Neutral	$105.00 ➝ $135.00	+0.52%
11/15/2024	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	M. Mayo Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Underweight ➝ Equal Weight	$107.00 ➝ $142.00	+7.22%
Get the Latest News and Ratings for MS and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Morgan Stanley and its competitors with MarketBeat's FREE daily newsletter.
10/17/2024	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	R. Ramsden Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Neutral ➝ Neutral	$106.00 ➝ $121.00	+0.82%
10/17/2024	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Sector Perform ➝ Sector Perform	$108.00 ➝ $122.00	+1.66%
10/17/2024	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Overweight ➝ Overweight	$121.00 ➝ $135.00	+13.09%
10/17/2024	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$120.00 ➝ $135.00	+12.69%
10/8/2024	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Neutral ➝ Neutral	$102.00 ➝ $112.00	+3.91%
7/18/2024	JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Market Perform
7/18/2024	BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Outperform ➝ Outperform	$116.00 ➝ $118.00	+10.42%
7/17/2024	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Outperform ➝ Outperform	$105.00 ➝ $115.00	+8.39%
7/17/2024	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Outperform ➝ Market Perform
4/17/2024	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$100.00 ➝ $106.00	+17.67%
4/16/2024	Cfra Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$97.00 ➝ $108.00	+20.82%
11/28/2023	Societe Generale Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Buy ➝ Hold	$80.00	+2.63%
11/20/2023	BNP Paribas Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Outperform ➝ Neutral	$85.00	+5.88%
10/23/2023	Odeon Capital Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Buy ➝ Hold	$79.15	+8.72%
10/20/2023	Wolfe Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	Underperform ➝ Peer Perform
8/1/2023	Atlantic Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Neutral ➝ Neutral	$85.00 ➝ $90.00	-1.70%
1/19/2023	Credit Suisse Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Outperform	$97.00 ➝ $102.00	+5.61%
1/6/2023	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target		$92.00 ➝ $84.00	-2.23%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Saturday at 11:01 AM ET.

Should I Buy Morgan Stanley Stock? MS Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Thursday, December 12, 2024. Please send any questions or comments about these Morgan Stanley pros and cons to contact@marketbeat.com.

Morgan Stanley
Bull Case

Here are some ways that investors could benefit from investing in Morgan Stanley:

The recent quarterly earnings report showed an earnings per share (EPS) of $1.88, exceeding the consensus estimate of $1.57 by $0.31, indicating strong financial performance.
As of the latest trading session, Morgan Stanley's stock price is $129.90, reflecting a solid market position and investor confidence.
The company has a robust market capitalization of $209.27 billion, which suggests stability and the ability to weather market fluctuations.
Institutional investors and hedge funds own 84.19% of Morgan Stanley's stock, indicating strong institutional confidence in the company's future prospects.
The declared quarterly dividend of $0.925 per share, with an annualized yield of 2.85%, provides a steady income stream for investors.

Morgan Stanley
Bear Case

Investors should be bearish about investing in Morgan Stanley for these reasons:

The stock has experienced a slight decline of 0.3% recently, which may indicate short-term volatility and investor uncertainty.
With a debt-to-equity ratio of 3.14, Morgan Stanley has a relatively high level of debt compared to its equity, which could pose risks in a rising interest rate environment.
Recent insider selling, including a director selling 60,000 shares, may raise concerns about the company's future performance from those closest to it.
Analysts have mixed ratings, with several firms downgrading their outlook, which could signal potential challenges ahead for the company.
The company's quick ratio and current ratio are both at 0.80, suggesting potential liquidity issues that could affect its ability to meet short-term obligations.

MS Forecast - Frequently Asked Questions

: According to the research reports of 17 Wall Street equities research analysts, the average twelve-month stock price forecast for Morgan Stanley is $121.80, with a high forecast of $142.00 and a low forecast of $104.00.
: 17 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Morgan Stanley in the last year. There are currently 11 hold ratings and 6 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" MS shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in MS, but not buy additional shares or sell existing shares.
: According to analysts, Morgan Stanley's stock has a predicted downside of -1.33% based on their 12-month stock forecasts.
: Over the previous 90 days, Morgan Stanley's stock had 3 upgrades and 2 downgrades by analysts.
: Morgan Stanley has been rated by research analysts at Barclays, Citigroup, Hsbc Global Res, HSBC, Jefferies Financial Group, JPMorgan Chase & Co., Keefe, Bruyette & Woods, Royal Bank of Canada, The Goldman Sachs Group, UBS Group, and Wells Fargo & Company in the past 90 days.
: Morgan Stanley also publishes sell-side equities research reports and recommendations about other companies, which can be viewed at its brokerage rating page.
: Analysts like Morgan Stanley less than other "finance" companies. The consensus rating score for Morgan Stanley is 2.35 while the average consensus rating score for "finance" companies is 2.50. Learn more on how MS compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Ratings

Top Rated Stocks

More Ratings Tools

URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad)

>> Register for the Workshop Now

This page (NYSE:MS) was last updated on 12/21/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Morgan Stanley (MS) Stock Forecast & Price Target